Atea Pharmaceuticals Inc (NASDAQ: AVIR) is -11.34% lower on its value in year-to-date trading and has touched a low of $2.60 and a high of $4.14 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AVIR stock was last observed hovering at around $3.00 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $2.97, the stock is 1.61% and -1.26% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.64 million and changing -1.00% at the moment leaves the stock -10.73% off its SMA200. AVIR registered -20.59% loss for a year compared to 6-month loss of -16.34%. The firm has a 50-day simple moving average (SMA 50) of $3.0078 and a 200-day simple moving average (SMA200) of $3.326825.
The stock witnessed a -6.31% gain in the last 1 month and extending the period to 3 months gives it a -10.81%, and is 10.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.15% over the week and 6.48% over the month.
Atea Pharmaceuticals Inc (AVIR) has around 56 employees, a market worth around $254.01M and $0.00M in sales. Distance from 52-week low is 14.23% and -28.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.29%).
The EPS is expected to grow by 14.17% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Atea Pharmaceuticals Inc (AVIR) Top Institutional Holders
150.0 institutions hold shares in Atea Pharmaceuticals Inc (AVIR), with institutional investors hold 81.95% of the company’s shares. The shares outstanding are 84.46M, and float is at 67.52M with Short Float at 4.46%. Institutions hold 72.39% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 9.12 million shares valued at $30.19 million. The investor’s holdings represent 10.8251% of the AVIR Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 6.44 million shares valued at $21.3 million to account for 7.639 of the shares outstanding. The other top investors are BML CAPITAL MANAGEMENT, LLC which holds 6.38 million shares representing 7.5672% and valued at over $21.1 million, while ECOR1 CAPITAL, LLC holds 6.4589 of the shares totaling 5.44 million with a market value of $18.01 million.
Atea Pharmaceuticals Inc (AVIR) Insider Activity
The most recent transaction is an insider sale by BERGER FRANKLIN M, the company’s Director. SEC filings show that BERGER FRANKLIN M sold 359,606 shares of the company’s common stock on Dec 10 ’24 at a price of $2.85 per share for a total of $1.02 million. Following the sale, the insider now owns 0.45 million shares.
Still, SEC filings show that on Sep 17 ’24, Sommadossi Jean-Pierre (President, CEO, and Chairman) disposed off 33,941 shares at an average price of $4.05 for $0.14 million. The insider now directly holds 5,890,053 shares of Atea Pharmaceuticals Inc (AVIR).
